Dr. George R. Blumenschein
Claim this profileMD Anderson Cancer Center
Area of expertise
Non-Small Cell Lung Cancer
George R. Blumenschein has run 6 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Solid Tumors
George R. Blumenschein has run 5 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
The University Of Texas M.D. Anderson Cancer Center
Clinical Trials George R. Blumenschein is currently running
NVL-655
for NSCLC
This trial is testing a new drug called NVL-655 to see if it is safe and effective for patients with advanced ALK-positive lung cancer and other solid tumors. The drug works by blocking a protein that helps cancer cells grow. The study focuses on patients who have specific genetic changes and may not respond well to standard treatments. Newer treatments have been shown to improve outcomes in ALK-translocated lung cancer compared to older treatments.
Recruiting
1 award
Phase 1 & 2
7 criteria
AU-007
for Advanced Cancer
This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be administered either as a monotherapy, or in combination with a single loading dose of aldesleukin, or with both AU-007 and aldesleukin given every 2 weeks (Q2w). Once the recommended phase 2 dose (RP2D) of AU-007 plus aldesleukin was determined, (AU-007 Q2w plus a single loading dose of aldesleukin), AU-007 plus aldesleukin is also being administered with avelumab or nivolumab.
Recruiting
1 award
Phase 1 & 2
8 criteria
More about George R. Blumenschein
Clinical Trial Related
18 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments George R. Blumenschein has experience with
- Carboplatin
- Paclitaxel
- Sorafenib
- IMC-C103C
- Atezolizumab
- Aldesleukin
Breakdown of trials George R. Blumenschein has run
Non-Small Cell Lung Cancer
Solid Tumors
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does George R. Blumenschein specialize in?
George R. Blumenschein focuses on Non-Small Cell Lung Cancer and Solid Tumors. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is George R. Blumenschein currently recruiting for clinical trials?
Yes, George R. Blumenschein is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that George R. Blumenschein has studied deeply?
Yes, George R. Blumenschein has studied treatments such as Carboplatin, Paclitaxel, Sorafenib.
What is the best way to schedule an appointment with George R. Blumenschein?
Apply for one of the trials that George R. Blumenschein is conducting.
What is the office address of George R. Blumenschein?
The office of George R. Blumenschein is located at: MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.